Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

-1.64% (1Y)

Market Cap	5.15B
Revenue (ttm)	836.95M
Net Income (ttm)	-577.12M
Shares Out	193.20M
EPS (ttm)	-2.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,067,292
Average Volume	3,040,411
Open	26.67
Previous Close	26.67
Day's Range	25.89 - 27.25
52-Week Range	21.14 - 41.49
Beta	1.54
RSI	71.55
Earnings Date	Aug 29, 2025

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products. It also provides molecular diagnosis products, including nucleic acid extraction systems, real ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,276
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688298

Financial Performance

In 2024, SHA:688298's revenue was 827.92 million, an increase of 0.95% compared to the previous year's 820.16 million. Losses were -529.02 million, 33.1% more than in 2023.